Benzonatate 100mg Capsules Label Mix-up — Wrong Medication in Bottles
Benzonatate 100mg capsule bottles are mislabeled. Some contain Benzphetamine tablets instead, and vice versa. This medication mix-up affects 10 bottles distributed to one physician in Alpharetta, Georgia.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class I by the FDA, which requires a minimum severity score of 4. The label mix-up creates a medication safety hazard, as patients could receive an entirely different drug than prescribed. However, no illnesses or injuries have been reported as of the recall date.
Plain-English summary
Benzonatate 100mg capsules distributed by Calvin Scott & Company, Inc. (Albuquerque, NM) are subject to recall due to a labeling error. Bottles labeled as containing Benzonatate 100mg capsules actually contain Benzphetamine 50mg tablets, and vice versa, resulting in patients potentially receiving the wrong medication.
This product was distributed to one physician in Alpharetta, Georgia. Approximately 10 bottles are involved in this recall (lot CSI CS-20180W-004, expiration March 2022, NDC 67877-0573-05). Healthcare providers or patients who may have received this product should not use it. Patients and healthcare providers should contact Calvin Scott & Company, Inc., or their healthcare provider for guidance on the recall.
The recalled product
- Product
- Benzonatate capsules, 100mg, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 67877-0573-05
- Manufacturer
- Calvin Scott & Company, Inc.
- Hazard
- label-mix-up
- medication-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- CSI Lot: CS-20180W-004
- Exp 3/22
Distribution
Distributed in 1 state:
- GA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27